CrownBio’s validated syngeneic tumor models support the transition into the clinic.
Our syngeneic model data, including RNAseq, tumor growth curve, and response to standard of care agents are available within MuBase®. Not registered yet?
Want to interrogate your compound's PD effect or efficacy in vivo?
Ask us about MuScreen™, our large scale staggered syngeneic screening platform to fast track strategies.
Fill in the form and we will be in touch soon!
Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
[fa icon="phone"] (858) 622-2900
[fa icon="envelope"] busdev@crownbio.com
[fa icon="home"] 16550 West Bernardo Drive, San Diego CA 92127